Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
World Neurosurgery|September 11, 2019
Combining Ellagic Acid with Temozolomide Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma ModelAbdurrahman Çetin, Burcu BiltekinInternational Journal of Molecular Sciences|July 15, 2026
Modulation of Drug Resistance and Apoptotic Pathways Underlies the Enhanced Antitumor Effect of Ellagic Acid-Irinotecan Combination in GliomaBurcu Biltekin, Abdurrahman ÇetinTurkish Neurosurgery|July 30, 2019
Ellagic Acid Enhances Antitumor Efficacy of Temozolomide in an in vitro Glioblastoma ModelAbdurrahman Cetin, Burcu BiltekinWorld Neurosurgery|September 14, 2019
Ellagic Acid Enhances the Antitumor Efficacy of Bevacizumab in an In Vitro Glioblastoma ModelAbdurrahman Çetin, Burcu Biltekin, Sevgin DegirmenciogluInternational Journal of Molecular Sciences|April 14, 2026
Resveratrol as a Modulator of Adriamycin-, Taxol-, and Cisplatin-Induced Cytotoxicity in MCF-7 Breast Cancer CellsBurcu Biltekin, Hafize Uzun, Ayhan BilirRevista Da Associacao Medica Brasileira (1992)|August 10, 2022
Antitumor activity of irinotecan with ellagic acid in C6 glioma cellsAbdurrahman Cetin, Burcu Biltekin, Huseyin OzevrenCurrent Issues in Molecular Biology|May 27, 2026
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia CellsBurcu Biltekin, Yusuf Elgormus, Ayhan BilirRomanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|January 7, 2024
In vitro effects of heparin-binding epidermal growth factor on adhesion stage of implantationBurcu Biltekin, Ayhan Bilir, Ismail Seckin, et al.Biology|April 13, 2026
Cytostatic and Non-Apoptotic Effects of Vinorelbine-Based Therapy in 3D Endometrial Cancer SpheroidsBerna Yıldırım, Burcu Biltekin, Mete Hakan Karalök, et al.Biomedicines|March 28, 2026
Mitochondrial Injury Accompanied by Intermediate Filament Remodeling Following Lithium Chloride Exposure in 3D Endometrial Cancer SpheroidsBerna Yıldırım, Burcu Biltekin, Mete Hakan Karalök, et al.Pageof 3